李晓 女， 上海血液病研究所副所长；上海市血液分会委员；中华血液杂志编委；白血病.淋巴瘤杂志编委；博导，教授，主任医师；多年从事血液学临床工作和基础研究，对各种血液科疾病的诊断和治疗具备丰富经验。近年主要从事血液系统最常见的恶性疾病骨髓增生异常综合征（MDS）的发病机制与临床诊治的研究。曾两次前往美国最大的血液病研究及移植中心进行共同研究及交流。近年来获得多项科研资助，获得上海市科技进步奖2项。以第一作者或通讯作者身份发表SCI论著18篇(总影响因子37.638)。2007/2008年度获上海市三八红旗手称号。曾经和正在进行的重要课题李晓等.三氧化二砷/TRAIL作为MDS治疗新药的临床前期研究(上海市科委重点项目2004)( 044119630)李晓等. MDS和急性髓细胞白血病恶性克隆细胞生物学特性研究(上海市科委登山计划2006)(064119635)李晓等参与--骨髓增生异常综合症的规范化诊断与治疗策略（国家“十一五”科技支撑计划2008BAI61B02）李晓等.骨髓增生异常综合征的规范化诊断与分层治疗（申康集团适宜技术应用项目SHDC12010202）已获得奖项李晓等 2005年上海市科技进步叁等奖（2005093037）李晓等《骨髓增生异常综合征发病机制和规范诊治的相关研究 》 2010年上海市科技进步叁等奖（20104387-3-D01）SCI论著（通讯作者）1. He Qi, Li Xiao, Wu Lingyun et al. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis. Ann Hematol. 2006; 85(2):95-101.2. Wu Lingyun, Li Xiao, Chang Chunkang, et al. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome. Int J Lab Hematol 2008;30(5):390-399 3. Wu Lingyun, Li Xiao, Su Jiying, et al. Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome. Leukemia Lymphoma, 2009; 50(9): 1461–14674. Xu Li, Chang Chunkang, Li Xiao,et al. Appropriate Timing of G-CSF Use After Mobilization Chemotherapy Significantly Increases the Yield of CD341 Cells in autoPBSCT . J Clin Apheresis 2009,6;24(6):232-237. 5. Xu Feng, Li Xiao, Wu Lingyun, et al. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes. Br J Haematol. 2010;149 (4):587-97. 6. Zhang Zheng, Zhang Qianqiao, He Qi, Li Xiao,et al. In vitro deprivation Of CD8CD57 T cells promotes the malignant growth of bone marrow Colony cells in patients with ower-risk myelodysplastic syndrome .Exp Hematol 2010; 38:677–684 7. He Qi,Li Xiao, Zhang Zheng, et al. Overexpression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes Cancer Invest, 2010；28:983–9888. Zhang Zheng, Xu Feng, Li Xiao, et al. Removal of autologous activated CD4-positive T lymphocytes also results in increased colony-forming units in patients with low and intermediate-1 risk myelodysplastic syndromes. Eur J Haematol,2011；86 (47–56)9. Xu Feng,Li Xiao, Wu Lingyun，et，al. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring Ann Hematol 2011,90:643–65310. Wu Lingyun, Li Xiao, Su Jiying, et al. Efficacy and safety of CHG regimen (low-dose cytarabine,homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS J Cancer Res Clin Oncol (2011) 137:1563–1569 SCI论著（第一作者）11.Li Xiao, Eileen Bryant, H. Joachim Deeg. Simultaneous Demonstration of Clonal Chromosome Abnormalities and Apoptosis in Individual Marrow Cells in Myelodysplastic Syndrome. Int J Hematol 2004; 80(2): 140—145. 12. Li Xiao & Pu Quan. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes. Leukemia Lymphoma 2005;46(3): 387-391.13.Li Xiao Wu Lingyun, Ying Shaoxu, et al. Wilmms’ tumor gene (WT1) is predominantly expressed in clonal hematopoietic cells in myelodysplastic syndromes. Leukemia Lymphoma 2007; 48[3]: 601-604. 14.Li Xiao, Wu Lingyun, Ying Shaoxu, et al. Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes. Leukemia Lymphoma 2007；48[7]：1353 – 1371 15.Li Xiao, Wu Lingyun, Ying Shaoxu, et al. Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows. Int J Hematol. 2008; 87(2):176-83. 16.Li Xiao, Song Luxi, Tao Ying, et al. Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples. J Cancer Res Clin Oncol 2009; 135:687–693 17.Li Xiao，Liao Qiong，Zhang yan et al. Experimental and clinical characteristics in myelodysplastic syndrome patients with or without HLA-DRI5 allele. Hematol Oncol. 2010; 28:98-103.18. Li Xiao, Xu Feng, He Qi, et al. Comparison of Immunological Abnormalities of Lymphocytes in Bone Marrow in Myelodysplastic Syndrome (MDS) and Aplastic Anemia (AA). Inter Med 2010 49:1349-1355